IP Verse

Transgenic Animals Expressing Chimeric Antibodies For Use In Preparing Human Antibodies

Patent No. EP2003960 (titled "Transgenic Animals Expressing Chimeric Antibodies For Use In Preparing Human Antibodies") was filed by E R Squibb & Sons on Mar 30, 2007. The application was issued on Jun 10, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TRIDICOMar 10, 2016POTTER CLARKSON
REGENERON PHARMACEUTICALSMar 9, 2016J A KEMP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2003960

E R SQUIBB & SONS
Application Number
EP07754714A
Filing Date
Mar 30, 2007
Status
Revoked
Mar 23, 2018
Publication Date
Jun 10, 2015
External Links
Slate, Register , Google Patents